Orzel Spolka Akcyjna

WSE:ORL Stock Report

Market Cap: zł34.0m

Orzel Spolka Akcyjna Past Earnings Performance

Past criteria checks 0/6

Orzel Spolka Akcyjna's earnings have been declining at an average annual rate of -5.7%, while the Chemicals industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 11.3% per year.

Key information

-5.71%

Earnings growth rate

-8.31%

EPS growth rate

Chemicals Industry Growth32.56%
Revenue growth rate11.28%
Return on equity-6.38%
Net Margin-4.27%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

Orzel Spolka Akcyjna (WSE:ORL) Has More To Do To Multiply In Value Going Forward

Jul 24
Orzel Spolka Akcyjna (WSE:ORL) Has More To Do To Multiply In Value Going Forward

Calculating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)

Dec 22
Calculating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)

If EPS Growth Is Important To You, Orzel Spolka Akcyjna (WSE:ORL) Presents An Opportunity

Sep 29
If EPS Growth Is Important To You, Orzel Spolka Akcyjna (WSE:ORL) Presents An Opportunity

Should You Be Adding Orzel Spolka Akcyjna (WSE:ORL) To Your Watchlist Today?

May 13
Should You Be Adding Orzel Spolka Akcyjna (WSE:ORL) To Your Watchlist Today?

If You Like EPS Growth Then Check Out Orzel Spolka Akcyjna (WSE:ORL) Before It's Too Late

Jan 25
If You Like EPS Growth Then Check Out Orzel Spolka Akcyjna (WSE:ORL) Before It's Too Late

Estimating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)

Aug 03
Estimating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)

A Look At The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)

Mar 12
A Look At The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)

Orzel Spolka Akcyjna (WSE:ORL) Has A Somewhat Strained Balance Sheet

Dec 11
Orzel Spolka Akcyjna (WSE:ORL) Has A Somewhat Strained Balance Sheet

Revenue & Expenses Breakdown

How Orzel Spolka Akcyjna makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WSE:ORL Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2517-160
31 Dec 2417050
30 Sep 2418260
30 Jun 2417250
31 Mar 2417250
31 Dec 2317250
30 Sep 2318340
30 Jun 2316240
31 Mar 2315240
31 Dec 2215340
30 Sep 2214240
30 Jun 2214240
31 Mar 2214340
31 Dec 2113330
30 Sep 2112230
30 Jun 2112230
31 Mar 2112130
31 Dec 2011130
30 Sep 2011130
30 Jun 2011230
31 Mar 2011230
31 Dec 1912230
30 Sep 1911220
30 Jun 1911120
31 Mar 1910120
31 Dec 1810120
30 Sep 1811020
30 Jun 1810030
31 Mar 189-130
31 Dec 179-130
30 Sep 178-230
30 Jun 178-230
31 Mar 177-230
31 Dec 166-130
30 Sep 166-260
30 Jun 166-160
31 Mar 166-260
31 Dec 156-260
30 Sep 156-330
30 Jun 156-330
31 Mar 156-420
31 Dec 147-530
30 Sep 1417-340

Quality Earnings: ORL is currently unprofitable.

Growing Profit Margin: ORL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ORL is unprofitable, and losses have increased over the past 5 years at a rate of 5.7% per year.

Accelerating Growth: Unable to compare ORL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ORL is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.3%).


Return on Equity

High ROE: ORL has a negative Return on Equity (-6.38%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/30 20:55
End of Day Share Price 2025/07/25 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Orzel Spolka Akcyjna is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.